All
Endocrine Therapy Effective Subsequent Advanced Breast Cancer Treatment
January 16th 2024Endocrine therapy, particularly when administered in combination with Verzenio (abemaciclib), is effective when compared with chemotherapy among patients with metastatic breast cancer who experienced disease progression on Ibrance (palbociclib), according to recently published research.
Enrollment Continues in Study Evaluating ONCT-534 For Advanced Prostate Cancer
January 11th 2024Patients continue to be enrolled in a study evaluating the dual-action androgen receptor inhibitor ONCT-534 for the treatment of patients with advanced prostate cancer who are relapsed or refractory to approved androgen receptor pathway inhibitors (ARPIs).